Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by Cerity Partners LLC

Cerity Partners LLC raised its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 21.4% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 49,876 shares of the company’s stock after purchasing an additional 8,781 shares during the quarter. Cerity Partners LLC’s holdings in Doximity were worth $2,173,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. Charles Schwab Investment Management Inc. raised its position in shares of Doximity by 4.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 753,001 shares of the company’s stock valued at $32,808,000 after acquiring an additional 31,966 shares in the last quarter. Banco Santander S.A. bought a new stake in Doximity during the third quarter valued at $647,000. First Horizon Advisors Inc. raised its holdings in shares of Doximity by 22.5% during the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock worth $91,000 after purchasing an additional 384 shares during the period. Commerce Bank bought a new position in shares of Doximity in the 3rd quarter worth about $314,000. Finally, Prospera Private Wealth LLC acquired a new position in shares of Doximity in the 3rd quarter valued at about $133,000. Institutional investors own 87.19% of the company’s stock.

Doximity Stock Performance

Shares of NASDAQ:DOCS opened at $53.00 on Monday. The stock has a market capitalization of $9.89 billion, a price-to-earnings ratio of 60.92, a PEG ratio of 4.25 and a beta of 1.30. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $61.75. The company has a 50 day moving average price of $45.86 and a 200 day moving average price of $36.09.

Analyst Ratings Changes

Several research firms recently weighed in on DOCS. The Goldman Sachs Group assumed coverage on shares of Doximity in a research note on Friday, November 15th. They set a “neutral” rating and a $58.00 price objective on the stock. Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $33.00 to $53.00 in a report on Thursday, November 14th. Wells Fargo & Company upgraded Doximity from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $19.00 to $41.00 in a research note on Friday, November 8th. Robert W. Baird boosted their price target on shares of Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a report on Tuesday, September 17th. Finally, Raymond James reaffirmed an “outperform” rating and issued a $65.00 price objective (up previously from $37.00) on shares of Doximity in a report on Friday, November 8th. Eleven research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $52.27.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.